Investigators sought to determine the effect of combined therapy with aspirin and statins on the incidence of hepatocellular carcinoma.
A team of investigators examined the potential of fecal and salivary microbiota to serve as diagnostic biomarkers for pancreatic ductal adenocarcinoma.
Researchers investigated the association between NAFLD and the risk of extrahepatic cancers.
More than half of melanoma cases diagnosed among White patients in 2014 may represent cases of overdiagnosis, a study suggests.
Researchers sought to determine if adding atezolizumab to therapy with capecitabine and bevacizumab would improve progression-free survival in refractory metastatic colorectal cancer.
Risk of stage-specific Merkel cell carcinoma (MCC) recurrence and mortality over time since diagnosis is estimated.
Investigators assessed the incidence of colorectal cancer and mortality rates following the application of a fecal immunochemical testing-based screening program.
Analysis of messenger RNA, microRNA, and protein-encoding genes may predict the risk of papillary thyroid cancer recurrence.
Data were analyzed from patients diagnosed with CLL between 2000 and 2020 from 77 institutions affiliated with the ERIC.
The findings support the use of acalabrutinib in patients with relapsed/refractory CLL, including those with high-risk features.
